Biliary tract carcinoma (bile duct carcinoma)

1. introduction

Biliary tract carcinoma, also known as cholangiocarcinoma, is a rare but aggressive malignant tumor of the biliary tract. It can develop inside (intrahepatic) or outside (extrahepatic) the liver.
It mostly affects older people, and somewhat more frequently men.

Risk factors include chronic inflammation of the bile ducts, gallstones, primary sclerosing cholangitis (PSC), parasitic infections (e.g. Opisthorchis viverrini) and toxic pollution (e.g. vinyl chloride, nitrosamines).

2. medical background

Biliary tract carcinoma develops from the epithelial cells of the bile ducts.
A distinction is made according to location:

• Intrahepatic cholangiocarcinoma - within the liver
• Perihilar carcinoma (Klatskin tumor) - in the area of the liver hilus
• Distal extrahepatic carcinoma - in the lower bile duct

Histologically, they are mostly adenocarcinomas that form mucus and grow locally invasively.
The disease often spreads along the bile ducts and vessels; metastases can occur early.

3. symptoms

The disease develops gradually. Typical signs are

• Jaundice (icterus) due to bile congestion
• Itching
• Upper abdominal pain, especially in the right upper abdomen
• Loss of appetite, nausea, weight loss
• Discolored stool and dark urine

As the symptoms remain unspecific for a long time, the diagnosis is often made late.

4. diagnostics

Important diagnostic steps are

• Laboratory: bilirubin, alkaline phosphatase, γ-GT, liver values
• Tumor markers: CA 19-9, CEA
• Imaging procedures: Ultrasound, CT, MRT/MRCP
• Endoscopic diagnostics (ERCP with biopsy)
• Histological confirmation of the diagnosis

5. conventional medical therapy

Surgical removal is only possible in the early stages.
Therapy options are:

• Surgical resection (curative option if localized)
• Chemotherapy (e.g. gemcitabine + cisplatin)
• Irradiation in selected cases
• Palliative measures for inoperable tumors - e.g. stent insertion, pain and nutrition therapy

The prognosis is generally unfavorable, especially if the diagnosis is made late.

6. complementary approach: frequency therapy

Frequency therapy is regarded as a complementary method based on biophysical oscillations and is intended to support the body's own regulatory processes.

For biliary tract carcinoma, the following frequencies are mentioned in alternative sources (informative):

CAFL frequencies: 2000 Hz, 2128 Hz, 727 Hz, 880 Hz, 664 Hz, 2489 Hz
EDTFL frequencies: 465 Hz, 880 Hz, 1550 Hz, 1865 Hz, 2170 Hz

Note: Frequency therapy does not replace conventional medical treatment. If desired, it can be used as an adjunct to support general regulation.

7. conclusion

Biliary tract carcinoma is a serious, rare cancer of the biliary tract.
Early detection is difficult, which is why prevention and consistent treatment of biliary tract diseases are particularly important.
An integrative approach that combines conventional medicine with supportive procedures such as frequency therapy can promote well-being and quality of life.

⚠️ Disclaimer on frequency therapy

Frequency therapy is a complementary procedure whose effectiveness has not been scientifically proven.
It does not replace a medical examination, diagnosis or treatment.
All frequencies and information mentioned here are for general information purposes only and should not be understood as a promise of healing.
Patients should always consult qualified doctors or therapists before using alternative methods or changing treatments.